Dear Valued Customers and Channel Partners,
The Kings Global Biotech Ltd team wants to update you regarding our response to the still-unfolding 2019 novel coronavirus (COVID-19) global outbreak. The health and safety of our employees and partners remain our top priority as we continue working diligently to identify potential impacts to our supply chain of medicines.
Our team is following all government recommendations and regulations designed to protect worker health and safety. International travel is currently restricted for our global team.
Our staff across India continues working in accordance with the company’s Business Continuity Plan. Our warehouses in Pune, are currently closed due to Lockdown in Pune and suppose to continue normal operations after 14th April.
Since total Lockdown in Pune, India for 21 days from now our employees have used the company’s work-from-home solutions to continue assisting our customers with their business needs.
As India continues reporting an improved situation, the office will reopen after 14th April and will be fully staffed by 15th April 2020.\
However, lead times have expanded as the manufacturing factories work through reduced capacity due to limited labor availability and raw materials delays.
Due to the excellent support Kings Global Biotech receives from its world-class manufacturing partners, the company is well-stocked with global inventory to satisfy customers’ needs and to address any supply chain shortages.
But we regret to inform you that due to the current Lockdown Situation, our transportation partners and logistics partner may not be able to fulfill deliveries on time and there may be a delay in the shipments.
Our team is actively monitoring the dynamic situation and will continue providing necessary updates. We remain optimistic that our strong partnerships will continue resulting in mutual success and customer satisfaction.
Should you need further assistance, please contact our associated sales leader for support.
Thank you for your patience and understanding as we work through this challenging time.